A university has been awarded a £2 million grant to pursue an "innovative" strand of research into cancer.
Professor Karim Labib and his team at Dundee University will explore the role one of the most fundamental processes in cell biology plays in the disease with the help of the funding from Cancer Research UK.
Experts hope the work will aid the discovery of new and better ways to treat cancer.
The research will centre around the vital process by which cells copy their own chromosomes and then make new cells, the university said.
Chromosomes contain the genetic blueprint that makes us who we are and this information must be copied perfectly for new cells to survive and carry out their function.
When the copying process goes wrong, it can lead to cancer as abnormal cells are created.
Proteins in the cell combine to build a molecular "machine" called the replisome, which plays a key role in copying the double helix of DNA at the heart of each chromosome.
The replisome is only built once during the life of each cell, and is then "disassembled" to ensure that cells make just one copy of each chromosome.
Previous research by the team has suggested inhibiting this replisome disassembly could kill certain kinds of cancer cells, the university said.
The new study by Professor Labib and his colleagues in the MRC Protein Phosphorylation and Ubiquitylation Unit (PPU) at Dundee will build on this work, which looks at the cell processes in a small worm called Caenorhabditis elegans.
Professor Labib said: "I am very grateful to Cancer Research UK for their support, which will enable us to expand our work with animal cells and hopefully gain insight into an important process that is defective in particular human cancers, suggesting future approaches to new therapies."
Dr Catherine Pickworth, of Cancer Research UK, added: "It is exciting to see Professor Labib taking his work on the nuts and bolts of cell replication and progressing it from yeast to animal cells.
"Hopefully his research will help to understand if targeting these processes could suggest new approaches to targeting cancer cells in humans.
"Cancer Research UK funds innovative research like this because it is a vital part of finding new and better ways to treat cancer and we're looking forward to following his work as it progresses."
ends
Why are you making commenting on The Herald only available to subscribers?
It should have been a safe space for informed debate, somewhere for readers to discuss issues around the biggest stories of the day, but all too often the below the line comments on most websites have become bogged down by off-topic discussions and abuse.
heraldscotland.com is tackling this problem by allowing only subscribers to comment.
We are doing this to improve the experience for our loyal readers and we believe it will reduce the ability of trolls and troublemakers, who occasionally find their way onto our site, to abuse our journalists and readers. We also hope it will help the comments section fulfil its promise as a part of Scotland's conversation with itself.
We are lucky at The Herald. We are read by an informed, educated readership who can add their knowledge and insights to our stories.
That is invaluable.
We are making the subscriber-only change to support our valued readers, who tell us they don't want the site cluttered up with irrelevant comments, untruths and abuse.
In the past, the journalist’s job was to collect and distribute information to the audience. Technology means that readers can shape a discussion. We look forward to hearing from you on heraldscotland.com
Comments & Moderation
Readers’ comments: You are personally liable for the content of any comments you upload to this website, so please act responsibly. We do not pre-moderate or monitor readers’ comments appearing on our websites, but we do post-moderate in response to complaints we receive or otherwise when a potential problem comes to our attention. You can make a complaint by using the ‘report this post’ link . We may then apply our discretion under the user terms to amend or delete comments.
Post moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours.
Read the rules here